Natixis Bleichroeder
Natixis Bleichroeder Upgrades Thoratec (THOR) to Buy
Natixis Bleichroeder upgrades Thoratec (Nasdaq: THOR) from Hold to Buy ...
Natixis Bleichroeder Upgrades Unilever (UN) to Add
Natixis Bleichroeder upgrades Unilever (NYSE: UN) from Reduce to Add ...
Natixis Bleichroeder Upgrades Valero Energy (VLO) to Buy
Natixis Bleichroeder upgrades Valero Energy (NYSE: VLO) from ...
AGA Medical (AGAM) Sees IPO Price of $15-$16
AGA Medical Holdings (Nasdaq: AGAM) has filed an amended registration statement with the SEC for an initial public offering of its common stock ...
Natixis Bleichroeder Upgrades Halliburton (HAL) to Buy; Year of Improvements
View Older Stories
Natixis Bleichroeder upgrades Halliburton (NYSE: HAL) from Hold to Buy. Price target increased from $24 to $38.
Natixis analyst says, "As the energy services cycle begins anew, we are comfortable with ...
-
Natixis Bleichroeder Initiates Coverage on Seahawk Drilling (HAWK) with a Buy
-
Barron's Article Makes Comments on Steris (STE); Sees Potential For Continued Growth With Flu Season Upon Us
-
ATP Closes Previously Announced Public Offering of Common Stock
-
PennantPark Investment Corporation Prices Public Offering
-
Merriman Curhan Ford Hires Veteran C.E. Unterberg, Towbin and UBS Investment Bankers
-
PennantPark (PNNT) to Offer 8M Shares of Common Stock
-
Jefferies Expands Healthcare Equity Research Effort
-
Helix (HLX) Commences Secondary Public Offering of 20M Shares of Cal Dive (DVR) Stock
-
Helix Commences Secondary Public Offering of Cal Dive Common Stock
-
Helix Commences Secondary Public Offering of Cal Dive Common Stock
-
Natixis Bleichroeder Upgrades ZOLL Medical (ZOLL) to Buy
-
Natixis Bleichroeder Upgrades Disney (DIS) to Hold
-
Natixis Bleichroeder Downgrades WuXi PharmaTech (WX) to Hold
-
Natixis Bleichroeder Downgrades Willbros Group (WG) to Hold
-
Natixis Bleichroeder Downgrades Kendle International (KNDL) to Hold
-
Natixis Bleichroeder Downgrades CBS Corp (CBS) to Sell
-
Notable Analyst Rating Changes 8/3: MMM, WEN, GPS, BIDU, JCP, OWW, NDAQ Upgraded; HURN, ANN, E, ROST Downgraded
-
Natixis Bleichroeder & Credit Suisse Downgrade Eni (E)
-
Natixis Bleichroeder Downgrades Tesoro (TSO) to Hold
-
Cephalon (CEPH) volatility flat into EPS and generic drug competition outlook
-
Usec (USU) volatility at 105 after shares sell off after DOE denies loan application for Project
-
Natixis Bleichroeder Cuts USEC Inc. (USU) to Sell
-
Natixis Bleichroeder Downgrades Shutterfly (SFLY) to Hold; Valuation Call
-
Natixis Bleichroeder Initiates Coverage on NxStage Medical (NXTM) with a Buy
-
Natixis Bleichroeder Downgrades Halliburton (HAL) to Hold
-
Natixis Bleichroeder Upgrades Eli Lilly (LLY) to Buy
-
Merck & Co. (MRK) Slammed On Speculation After Trial Abruptly Halted
-
Notable Analyst Rating Changes 7/9: GS, KBH, RIMM, ERTS Upgraded; KNXA, GET, MRK, VRX Downgraded
-
Natixis Bleichroeder Lifts Price Target on Targacept (TRGT) to $7.50
-
Natixis Bleichroeder Downgrades Merck & Co (MRK) to Hold
-
Natixis Bleichroeder Downgrades Carrizo Oil & Gas (CRZO) to Hold
-
Natixis Bleichroeder Downgrades Swift Energy (SFY)
-
Natixis Bleichroeder Upgrades Vanda Pharmaceuticals (VNDA) to Buy On Surprise Iloperidone Approval
-
Natixis Bleichroeder Downgrades Discovery (DISCA) to Hold; Valuation Call
-
Time Warner (TWX) volatility elevated at 68; shares rally 6%
-
Natixis Bleichroeder Starts Celera Corporation (CRA) at Buy
-
Natixis Bleichroeder Upgrades King Pharmaceuticals (KG) to Buy
-
Morning Movers 3/4: GE (GE) Sinks Lower, Big Lots (BIG) Up on Strong Results
-
Natixis Bleichroeder Upgrades McDermott International (MDR) to Buy
-
Natixis Bleichroeder Downgrades Somaxon Pharmaceuticals (SOMX) to Hold
-
Natixis Bleichroeder Upgrades Cal Dive (DVR) to Buy
-
Natixis Bleichroeder Upgrades Alpha Natural Resources (ANR) to Buy
-
Medicis (MRX): Downgraded to Sell..er..Hold at Natixis Bleichroeder
-
Natixis Bleichroeder Downgrades Walt Disney (DIS) to Sell
-
Natixis Bleichroeder Upgrades InterMune (ITMN) to Buy
-
Natixis Bleichroeder Upgrades Pain Therapeutics (PTIE) to Hold
-
Natixis Bleichroeder Upgrades King Pharmaceuticals (KG) to Buy
-
Natixis Bleichroeder Starts InterMune (ITMN) at Hold
-
Natixis Bleichroeder Downgrades World Wrestling Entertainment (WWE) to Hold
-
Wall Street Throws In the Towel On Amylin (AMLN) Following New Byetta Patient Deaths
